Bivatuzumab, CAS 214559-60-1

Product Description: Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Leuci V,et al. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. 2018 Feb 15;7(5):e1423167.

CAS Number: 214559-60-1

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99281-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99281-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK